Alyeska Investment Group, L.P.

Position in LRMR — Larimar Therapeutics, Inc.

CIK 1453072 CHICAGO, IL

Position in LRMR

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,882,493

-$894,956 QoQ

Shares Held

617,211

0.0% QoQ

Ownership

0.594%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#23

of 163 holders

Holding Since

Sep 2022

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Alyeska Investment Group, L.P. holds $989,063,778 across 83 Biotechnology names. LRMR ranks #66 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	659,279	$123,469,771
2	IONS	Ionis Pharmaceuticals Inc	1,417,916	$112,426,559
3	PTGX	Protagonist Therapeutics, Inc	889,298	$109,010,148
4	XENE	Xenon Pharmaceuticals Inc.	697,692	$42,112,689
5	MRNA	Moderna, Inc.	560,819	$39,274,154
6	KYMR	Kymera Therapeutics, Inc.	276,455	$31,701,094
7	LBRX	Lb Pharmaceuticals Inc	863,947	$28,039,399
8	PRAX	Praxis Precision Medicines, Inc.	80,846	$27,066,432

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,882,493	617,211	0.0%	Shares	Sole	2026-08-14
2026-03-31	$2,777,449	617,211	-33.5%	Shares	Sole	2026-05-15
2025-12-31	$3,534,998	927,821	-50.8%	Shares	Sole	2026-02-13
2025-09-30	$6,095,555	1,887,169	-9.1%	Shares	Sole	2025-11-17
2025-06-30	$5,999,298	2,075,882	+43.9%	Shares	Sole	2025-08-14
2025-03-31	$3,101,316	1,442,473	+46.6%	Shares	Sole	2025-05-15
2024-12-31	$3,808,377	984,077	+38.6%	Shares	Sole	2025-02-14
2024-09-30	$4,651,528	710,157	-13.6%	Shares	Sole	2024-11-14
2024-06-30	$5,957,230	821,687	+49.4%	Shares	Sole	2024-08-14
2024-03-31	$4,174,704	550,027	+313.3%	Shares	Sole	2024-05-15
2022-09-30	$425,833	133,073	—	Shares	Sole	2022-11-14
No filing history on record for this holder in this stock.